Equity Profile

ICUI

ICU Medical, Inc.

Health CareHealth Care Supplies$3.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly those used in infusion therapy and critical care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into how well ICU Medical is expanding its market presence and demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly those used in infusion therapy and critical care. As a key player in the healthcare supplies sector, its products are essential for patient care, especially in hospitals and clinics.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, ICU Medical reported an EPS of $1.97, significantly beating estimates by 48.12%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Continued focus on innovation in infusion systems.
Commitment to improving operational efficiency.
Expansion into new markets and product lines.

Expectations

Wall Street Expectations

Investors are generally optimistic about ICU Medical's upcoming earnings report, given its strong track record of beating EPS estimates in recent quarters.

Bull Case

If ICU Medical continues its trend of strong earnings surprises, it could lead to increased investor confidence and a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's strong history of EPS surprises, this number will be crucial in determining market reaction.

What guidance will management provide for revenue growth in the upcoming quarters?

Investors will be looking for signs of sustained growth and market expansion, which are critical for long-term confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating ICU Medical's ability to sustain its growth trajectory, especially given its recent strong EPS surprises.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a higher expected move than historical averages, indicating potential for a larger reaction.

Management's focus on innovation could lead to unexpected revenue growth.

Key Risk

If the EPS comes in below $1.50, it could challenge the current positive sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is under scrutiny as investors weigh the company's ability to maintain its growth momentum amid increasing competition.

Bull Confirmed If

An EPS of $2.00 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.50 would raise concerns about the company's growth trajectory and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of over 5%, suggesting that investors expect significant volatility around the earnings announcement.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.7%, with a raw directional average of +3.1% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests a potential stock increase of around 0.93%, confirming the company's strong performance.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await clearer guidance.

Miss

A miss could lead to a decline, with historical averages suggesting a potential drop of around 2.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market expansion strategies and geographic growth.
3Details on cost management initiatives and their effects on margins.
4Management's outlook on industry trends and competitive landscape.
5Clarification on any changes in supply chain dynamics that could affect production.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly those used in infusion therapy and critical care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into how well ICU Medical is expanding its market presence and demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, ICU Medical reported an EPS of $1.97, significantly beating estimates by 48.12%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Continued focus on innovation in infusion systems.
Commitment to improving operational efficiency.
Expansion into new markets and product lines.

Expectations

Wall Street Expectations

Investors are generally optimistic about ICU Medical's upcoming earnings report, given its strong track record of beating EPS estimates in recent quarters.

Bull Case

If ICU Medical continues its trend of strong earnings surprises, it could lead to increased investor confidence and a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's strong history of EPS surprises, this number will be crucial in determining market reaction.

What guidance will management provide for revenue growth in the upcoming quarters?

Investors will be looking for signs of sustained growth and market expansion, which are critical for long-term confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating ICU Medical's ability to sustain its growth trajectory, especially given its recent strong EPS surprises.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a higher expected move than historical averages, indicating potential for a larger reaction.

Management's focus on innovation could lead to unexpected revenue growth.

Key Risk

If the EPS comes in below $1.50, it could challenge the current positive sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is under scrutiny as investors weigh the company's ability to maintain its growth momentum amid increasing competition.

Bull Confirmed If

An EPS of $2.00 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.50 would raise concerns about the company's growth trajectory and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of over 5%, suggesting that investors expect significant volatility around the earnings announcement.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests a potential stock increase of around 0.93%, confirming the company's strong performance.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await clearer guidance.

Miss

A miss could lead to a decline, with historical averages suggesting a potential drop of around 2.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market expansion strategies and geographic growth.
3Details on cost management initiatives and their effects on margins.
4Management's outlook on industry trends and competitive landscape.
5Clarification on any changes in supply chain dynamics that could affect production.